NASDAQ:HBIO Harvard Bioscience (HBIO) Stock Price, News & Analysis $0.43 -0.01 (-1.72%) As of 01:23 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock About Harvard Bioscience Stock (NASDAQ:HBIO) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get Harvard Bioscience alerts:Sign Up Key Stats Today's Range$0.42▼$0.4550-Day Range$0.40▼$0.5752-Week Range$0.28▼$3.04Volume484,934 shsAverage Volume4.61 million shsMarket Capitalization$19.33 millionP/E RatioN/ADividend YieldN/APrice Target$2.00Consensus RatingModerate Buy Company Overview Harvard Bioscience, Inc. develops, manufactures and distributes life science research instruments and consumables used by academic, biopharmaceutical and government laboratories worldwide. The company’s product portfolio spans cellular physiology, microfluidics, electrophysiology and lab automation, providing tools that enable researchers to study everything from cell behavior and organ function to drug delivery and tissue mechanics. Through its operating units—most notably Harvard Apparatus, BTX, Radnoti and Warner Instruments—Harvard Bioscience offers a diverse range of scientific equipment including precision pumps, stereotaxic instruments, electroporation and gene delivery systems, perfusion systems and microinjection tools. The company serves its customers via direct sales and an extensive distributor network, with significant operations in North America, Europe and the Asia‐Pacific region. Founded in 1901 and headquartered in Holliston, Massachusetts, Harvard Bioscience has grown through organic innovation and strategic acquisitions to support the evolving needs of life science research. The company maintains manufacturing and R&D facilities in the United States and Europe and is managed by an experienced team of professionals with backgrounds in engineering, sales and scientific product development.AI Generated. May Contain Errors. Read More Harvard Bioscience Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks79th Percentile Overall ScoreHBIO MarketRank™: Harvard Bioscience scored higher than 79% of companies evaluated by MarketBeat, and ranked 203rd out of 671 stocks in the computer and technology sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion3.5 / 5Analyst RatingModerate Buy Consensus RatingHarvard Bioscience has received a consensus rating of Moderate Buy. The company's average rating score is 2.50, and is based on 1 buy rating, 1 hold rating, and no sell ratings.Upside PotentialHarvard Bioscience has a consensus price target of $2.00, representing about 361.9% upside from its current price of $0.43.Amount of Analyst CoverageHarvard Bioscience has only been the subject of 1 research reports in the past 90 days.Read more about Harvard Bioscience's stock forecast and price target. Earnings and Valuation0.6 / 5Proj. Earnings GrowthN/A Price to Earnings Ratio vs. the MarketThe P/E ratio of Harvard Bioscience is -0.33, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Harvard Bioscience is -0.33, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioHarvard Bioscience has a P/B Ratio of 0.30. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.Read more about Harvard Bioscience's valuation and earnings. Short Interest3.0 / 5Short Interest LevelHealthy Percentage of Shares Shorted2.00% of the float of Harvard Bioscience has been sold short.Short Interest Ratio / Days to CoverHarvard Bioscience has a short interest ratio ("days to cover") of 0.7, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Harvard Bioscience has recently increased by 27.88%, indicating that investor sentiment is decreasing significantly. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldHarvard Bioscience does not currently pay a dividend.Dividend GrowthHarvard Bioscience does not have a long track record of dividend growth. Sustainability and ESG4.5 / 5Environmental Score-1.14 Percentage of Shares Shorted2.00% of the float of Harvard Bioscience has been sold short.Short Interest Ratio / Days to CoverHarvard Bioscience has a short interest ratio ("days to cover") of 0.7, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Harvard Bioscience has recently increased by 27.88%, indicating that investor sentiment is decreasing significantly. News and Social Media1.8 / 5News Sentiment0.30 News SentimentHarvard Bioscience has a news sentiment score of 0.30. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.89 average news sentiment score of Computer and Technology companies.News Coverage This WeekMarketBeat has tracked 8 news articles for Harvard Bioscience this week, compared to 16 articles on an average week.Search Interest5 people have searched for HBIO on MarketBeat in the last 30 days. This is an increase of 150% compared to the previous 30 days. Company Ownership1.7 / 5Insider TradingN/A Insider Buying vs. Insider SellingIn the past three months, Harvard Bioscience insiders have not sold or bought any company stock.Percentage Held by InsidersOnly 9.50% of the stock of Harvard Bioscience is held by insiders.Percentage Held by Institutions80.87% of the stock of Harvard Bioscience is held by institutions. High institutional ownership can be a signal of strong market trust in this company.Read more about Harvard Bioscience's insider trading history. Receive HBIO Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Harvard Bioscience and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. HBIO Stock News HeadlinesBenchmark Lowers Harvard Bioscience (NASDAQ:HBIO) Price Target to $2.00September 11, 2025 | americanbankingnews.comResilient Performance and Strategic Growth Drive Buy Rating for Harvard Bioscience Amid Market ChallengesSeptember 10, 2025 | tipranks.comYour Bank Account Is No Longer SafeWhat If Washington Declared That: YOUR Money ISN'T Actually Yours? Sounds insane, but that's exactly what the Department of Justice just admitted in court—claiming cash isn't legally your property. What does that mean? It means Washington thinks they can seize, freeze, or drain your accounts—whenever they want.September 15 at 2:00 AM | Priority Gold (Ad)Harvard Bioscience Appoints Stephen DeNelsky to BoardSeptember 9, 2025 | tipranks.comHarvard Bioscience, Inc. Appoints Stephen DeNelsky to Board of DirectorsSeptember 9, 2025 | quiverquant.comQHarvard Bioscience Announces Appointment of Stephen DeNelsky to Board of DirectorsSeptember 9, 2025 | globenewswire.comHarvard dropouts to launch ‘always on’ AI smart glasses that listen and record every conversationAugust 21, 2025 | msn.comBelgium’s Crown Princess Elisabeth Will Continue Her Studies at Harvard University This FallAugust 19, 2025 | msn.comSee More Headlines HBIO Stock Analysis - Frequently Asked Questions How have HBIO shares performed this year? Harvard Bioscience's stock was trading at $2.11 on January 1st, 2025. Since then, HBIO stock has decreased by 79.5% and is now trading at $0.4330. How were Harvard Bioscience's earnings last quarter? Harvard Bioscience, Inc. (NASDAQ:HBIO) issued its quarterly earnings data on Tuesday, November, 2nd. The medical instruments supplier reported $0.06 earnings per share for the quarter, hitting analysts' consensus estimates of $0.06. The medical instruments supplier had revenue of $29.66 million for the quarter, compared to the consensus estimate of $28.10 million. Harvard Bioscience had a negative net margin of 64.68% and a negative trailing twelve-month return on equity of 5.64%. Does Harvard Bioscience have any subsidiaries? Harvard Bioscience subsidiaries include Data Sciences International. Who are Harvard Bioscience's major shareholders? Top institutional shareholders of Harvard Bioscience include AMH Equity Ltd (7.94%), Harvey Partners LLC (4.81%), Geode Capital Management LLC (1.00%) and Pasadena Private Wealth LLC (0.55%). View institutional ownership trends. How do I buy shares of Harvard Bioscience? Shares of HBIO stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Harvard Bioscience own? Based on aggregate information from My MarketBeat watchlists, some other companies that Harvard Bioscience investors own include YETI (YETI), Advanced Micro Devices (AMD), Meta Platforms (META), NVIDIA (NVDA), Alphabet (GOOG), Stag Industrial (STAG) and Tesla (TSLA). Company Calendar Last Earnings11/02/2021Today9/15/2025Next Earnings (Estimated)11/06/2025Fiscal Year End12/31/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorComputer and Technology Industry INSTRU - SCIENTFC Sub-IndustryLife Sciences Tools & Services Current SymbolNASDAQ:HBIO CIK1123494 Webwww.harvardbioscience.com Phone(508) 893-8999Fax508-429-5732Employees490Year Founded1901Price Target and Rating Average Price Target for Harvard Bioscience$2.00 High Price Target$2.00 Low Price Target$2.00 Potential Upside/Downside+358.7%Consensus RatingModerate Buy Rating Score (0-4)2.50 Research Coverage2 Analysts Profitability EPS (Trailing Twelve Months)($1.30) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income-$12.40 million Net Margins-64.68% Pretax Margin-64.17% Return on Equity-5.64% Return on Assets-2.15% Debt Debt-to-Equity RatioN/A Current Ratio0.81 Quick Ratio0.41 Sales & Book Value Annual Sales$88.75 million Price / Sales0.22 Cash Flow$0.10 per share Price / Cash Flow4.37 Book Value$1.45 per share Price / Book0.30Miscellaneous Outstanding Shares44,531,000Free Float40,301,000Market Cap$19.42 million OptionableOptionable Beta1.54 Social Links 7 Stocks to Buy And Hold ForeverEnter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising. Get This Free Report This page (NASDAQ:HBIO) was last updated on 9/15/2025 by MarketBeat.com Staff From Our PartnersOut of 18,347 Cryptocurrencies... This is the ONLY OneThe Single Most Undervalued DeFi Protocol You've Never Heard Of If there's one cryptocurrency you should b...Crypto 101 Media | SponsoredHe Called Nvidia at $1.10. Now, He Says THIS Stock Will…The original Magnificent Seven returned 16,894%—turning $7K into $1.18 million. Now, the man who called Nvi...The Oxford Club | SponsoredWhy Trump’s “Smart Dollar” could rewrite the rulesMUST SEE: Donald Trump's Radical Overhaul of the U.S. Dollar Congress just approved President Trump's lates...Stansberry Research | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredForget AI Stocks — This Device Will REPLACE the MicrochipWhile everyone's chasing the same AI plays, George Gilder is focused on something completely different. He ...Banyan Hill Publishing | SponsoredTrump's Law S.1582: $21T Dollar Revolution ComingDo you have money in any of these banks? Chase. Bank of America. Citigroup. Wells Fargo. U.S. Bancorp. I...Brownstone Research | SponsoredGENIUS Act: The Plot to Seize Your Cash?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Harvard Bioscience, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Harvard Bioscience With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.